公开(公告)号：WO2009043856A2

公开(公告)日：2009-04-09

申请号：PCT/EP2008/063106

申请日：2008-09-30

Applicant: UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORK ,  TEAGASC, - The Agriculture and Food Development Authority ,  ALIMENTARY HEALTH LTD. ,  O'MAHONY, Liam ,  SHANAHAN, Fergus ,  QUIGLEY, Eamonn ,  ROSS, Paul ,  STANTON, Catherine

Inventor： O'MAHONY, Liam ,  SHANAHAN, Fergus ,  QUIGLEY, Eamonn ,  ROSS, Paul ,  STANTON, Catherine

IPC: A61K35/74 ,  C12P7/64 ,  A23L1/30 ,  A61P25/28 ,  A61P1/00 ,  A61P17/00

CPC classification number: C12N1/20 ,  A23L33/135 ,  A61K31/201 ,  A61K35/74 ,  A61K35/744 ,  A61K35/745 ,  A61K35/747 ,  C12P7/6427 ,  C12P7/6472 ,  C12R1/01

Abstract: The current invention provides use of a CLA -producing bacterium for the in viv o conversion in the gut of polyunsaturated fatty acids to CLA. The CLA- producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.

Abstract translation: 本发明提供了用于在多不饱和脂肪酸肠中向CLA转化的CLA产生细菌的用途。 CLA产生细菌选自丙酸杆菌属，乳酸杆菌属，乳球菌属和链球菌属，以及双歧杆菌中的一种或多种。

公开(公告)号：WO1995023872A1

公开(公告)日：1995-09-08

申请号：PCT/IE1995000021

申请日：1995-02-28

Applicant: TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY ,  DUFFY, Geraldine ,  SHERIDAN, James, J.

Inventor： TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY

IPC: C12Q01/24

CPC classification number: C12Q1/24 ,  C12N1/02 ,  G01N33/56911 ,  Y10S435/87 ,  Y10S435/975

Abstract: A means for the rapid detection of bacteria from a liquid culture or slurry is described. A membrane mounted on a solid support is immersed in a liquid culture for a time sufficient to allow bacteria to adhere to the membrane, the membrane is removed from the culture and the number of bacteria adhering to the membrane is counted. The membrane may be either an inanimate membrane or a biological membrane. A test kit for use in the method is also described.

Abstract translation: 描述了用于从液体培养物或浆液中快速检测细菌的方法。 将安装在固体支持体上的膜浸入液体培养物中足以允许细菌粘附到膜上的时间，从培养物中除去膜并计数粘附在膜上的细菌数。 膜可以是无生物膜或生物膜。 还描述了用于该方法的测试试剂盒。

公开(公告)号：WO2019229137A1

公开(公告)日：2019-12-05

申请号：PCT/EP2019/063989

申请日：2019-05-29

Applicant: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN ,  TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY

Inventor： LAVELLE, Edward ,  DOYLE, Sarah ,  HARTE, Ciaran ,  BRENNAN, Kiva ,  MEADE, Kieran

IPC: A61K39/39 ,  A61K31/711 ,  A61K31/7115 ,  A61K31/713 ,  A61P37/04 ,  A61K39/00

Abstract: The present application relates to an adjuvant which is suitable to be used in vaccines or other immunogenic compositions. Specifically, the adjuvant promotes the induction of interleukin-1 (IL-1), type 1 interferons (IFNs), such as IFNα, and IFNβ, type 2 interferons, such as IFNγ and/or tumour necrosis factor (TNF) response, such as TNFα, and elicits or enhances an immune response, preferably in neonatal, juvenile or paediatric animal and/or human populations.

公开(公告)号：WO2006114778A1

公开(公告)日：2006-11-02

申请号：PCT/IE2006/000025

申请日：2006-04-06

Applicant: TEAGASC- THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY ,  STANTON, Catherine ,  HILL, Colin ,  FITZGERALD, Ger ,  ROSS, Paul

Inventor： STANTON, Catherine ,  HILL, Colin ,  FITZGERALD, Ger ,  ROSS, Paul

IPC: C12N1/20 ,  A23L1/30 ,  A23K1/00

CPC classification number: A23K10/18

Abstract: The invention provides a probiotic composition to alleviate Salmonella infection in farm animals. The composition may comprise at least one of Lactobacillus murinus, Lactobacillus pentosus, Lactobacillus salivarius sub-species salivarius, and Pediococcus pentosaceus . The composition maybe formulated as an animal feedstuff, or as a pharmaceutical composition.

Abstract translation: 本发明提供了用于减轻农场动物沙门氏菌感染的益生菌组合物。 所述组合物可以包括鼠疫乳酸杆菌，戊糖乳杆菌，唾液乳杆菌唾液乳杆菌和戊糖片球菌中的至少一种。 组合物可以配制成动物饲料，或作为药物组合物。

公开(公告)号：WO2005034970A1

公开(公告)日：2005-04-21

申请号：PCT/IE2004/000143

申请日：2004-10-15

Applicant: TEAGASC THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY ,  UNIVERSITY COLLEGE CORK ,  ROSS, Paul ,  HALLAHAN, Stephen

Inventor： ROSS, Paul ,  HALLAHAN, Stephen

IPC: A61K35/74

CPC classification number: A61K35/744

Abstract: The invention relates to the live cultures of probiotic bacteria to treat infectious diseases in humans and animals. Food- grade or non-pathogenic cultures are used to treat localised infections.

Abstract translation: 本发明涉及用于治疗人和动物的感染性疾病的益生菌的活培养物。 食品级或非致病性培养物用于治疗局部感染。

公开(公告)号：WO2020176985A1

公开(公告)日：2020-09-10

申请号：PCT/CA2020/050283

申请日：2020-03-03

Applicant: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA ,  TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY

Inventor： WILLING, Benjamin ,  BOURRIE, Benjamin ,  COTTER, Paul

IPC: A23C9/127 ,  A23C9/12 ,  A61K35/20 ,  A61K35/74 ,  A61K35/744 ,  A61K35/747 ,  A61K36/06 ,  C12N1/16 ,  C12N1/20

Abstract: A method for preparing a kefir product involves providing bacterial strains selected from Acetobacter , Leuconostoc , Lactococcus , or Lactobacillus ; providing yeast strains selected from Pichia, Saccharomyces, Kazachstania , or Kluyveromyces ; adding the bacterial and yeast strains to milk to form a mixture; and allowing the mixture to ferment to yield the kefir product.

公开(公告)号：WO2009150183A1

公开(公告)日：2009-12-17

申请号：PCT/EP2009/057199

申请日：2009-06-10

Applicant: TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY ,  GUINEE, Timothy, P. ,  O'KENNEDY, Brendan, T. ,  KELLY, Philip, M. ,  MOUNSEY, John

Inventor： GUINEE, Timothy, P. ,  O'KENNEDY, Brendan, T. ,  KELLY, Philip, M. ,  MOUNSEY, John

IPC: A23C9/00 ,  A23C9/13 ,  A23C9/142 ,  A23C9/18 ,  A23C19/00 ,  A23C19/05 ,  A23J1/20

CPC classification number: A23C19/053 ,  A23C9/1307 ,  A23C9/1422 ,  A23C9/1425 ,  A23C9/1522 ,  A23J1/20

Abstract: The present invention relates to the development of micellar casein (MCCa) and milk protein concentrate (MPCCa) powders, with different calcium-to-casein ratios and buffering capacity. The invention also relates to the use of the MCCa and MPCCa powders in the preparation of reassembled milks. More specifically the invention relates to the use of such reassembled milks in the production of cheeses or cheese-style products

Abstract translation: 本发明涉及具有不同钙 - 酪蛋白比例和缓冲能力的胶束酪蛋白（MCCa）和乳蛋白浓缩物（MPCCa）粉末的开发。 本发明还涉及MCCa和MPCCa粉末在重新组装的乳制备中的用途。 更具体地，本发明涉及这种重新组装的奶在生产奶酪或奶酪样产品中的用途

公开(公告)号：WO2007096855A2

公开(公告)日：2007-08-30

申请号：PCT/IE2007/000027

申请日：2007-02-23

Applicant: TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY ,  UNIVERSITY COLLEGE CORK ,  ROSS, Paul ,  STANTON, Catherine ,  HILL, Colin ,  FITZGERALD, Ger

Inventor： ROSS, Paul ,  STANTON, Catherine ,  HILL, Colin ,  FITZGERALD, Ger

IPC: C12N1/20 ,  C12P1/04 ,  A61K38/04 ,  C07K7/14 ,  A23L1/03 ,  A23J1/20

CPC classification number: C12R1/225 ,  A23L29/065 ,  A23L33/135 ,  A23L33/18 ,  A61K35/747 ,  A61K38/00 ,  C07K14/4741 ,  C07K14/8103 ,  C12R1/245

Abstract: The present invention relates to Angiotensin-I-converting enzyme inhibitors and to methods of producing such inhibitors comprising culturing a Lactobacillus strain in the presence of milk proteins. Strains useful in the production of these inhibitors are disclosed. The invention also relates to functional foods comprising such inhibitors.

Abstract translation: 本发明涉及血管紧张素-I转换酶抑制剂及其制备方法，包括在乳蛋白存在下培养乳杆菌属菌株。 公开了可用于制备这些抑制剂的菌株。 本发明还涉及包含这种抑制剂的功能性食品。

公开(公告)号：WO2022214700A1

公开(公告)日：2022-10-13

申请号：PCT/EP2022/059545

申请日：2022-04-08

Applicant: UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK ,  TEAGASC - THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY

Inventor： O'TOOLE, Paul ,  VAN SINDEREN, Douwe ,  ROSS, Paul ,  MELGAR, Silvia

IPC: A23L33/135 ,  A23L33/00 ,  A61K35/747 ,  A61P1/00 ,  A61P3/10 ,  A61P37/08 ,  C12N1/20 ,  C12R1/225 ,  A61P37/02 ,  C12N9/24 ,  A23Y2220/63 ,  C12N1/205 ,  C12N9/2402 ,  C12R2001/225 ,  C12Y302/01065

Abstract: A strain of Lacticaseibacillus paracasei EM025-11 is described. The strain has an unusually broad catabolic activity including for prebiotics not normally utilized by commensal lactobacilli and is therefore suitable for inclusion in a synbiotic combination. The strain has also been found to adhere to but did not invade intestinal epithelial cells (IECs), which is an important probiotic trait (Fig. 1), and also demonstrates anti-inflammatory activity.

公开(公告)号：WO2020178308A1

公开(公告)日：2020-09-10

申请号：PCT/EP2020/055623

申请日：2020-03-04

Applicant: UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK ,  TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY

Inventor： ROSS, Reynolds Paul ,  STANTON, Catherine ,  HILL, Colin ,  RYAN, Anthony ,  O'SULLIVAN, Julie ,  WATKINS, Claire

IPC: A61K38/16 ,  C07K14/31

Abstract: An isolated lantibiotic is provided comprising amino acid sequence SEQ. ID No. 2 and at least one of amino acid sequences SEQ. ID No. 4 and SEQ. ID. No 6. Also provided is use of the lantibiotic in the treatment or prevention of infection by Group B Streptococcus or Corynebacterium xerosis. The invention further relates to isolated S. hominis strains and use of same in producing the lantibiotic. A vector is provided comprising nucleotides sequences for producing the lantibiotic.